Clinical trials

The European Union Clinical Trials Register allows you to search for protocol and results information on:

interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC

clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).

The EU Clinical Trials Register currently displays 44339 clinical trials with a EudraCT protocol, of which 7369 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).

Examples: Cancer AND drug name. Pneumonia AND sponsor name.
How to search [pdf]

Advanced Search:

Search tools

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Trials with a EudraCT protocol (44,339)
Paediatric studies in scope of Art45 of the Paediatric Regulation (18,700)

44,339 result(s) found. Displaying page 1,392 of 2,217.

EudraCT Number: 2004-001789-42

Sponsor Protocol Number: IC01/04/DKP

Start Date*: 2004-12-07

Sponsor Name:Laboratorios Menarini, S.A.

Full Title: A MULTICENTRE CLINICAL TRIAL EVALUATING THE ANALGESIC EFFICACY AND SAFETY OF DEXKETOPROFEN TROMETAMOL (50 mg i.v. FOLLOWED BY AN ORAL DOSAGE OF 25 mg t.i.d.) VERSUS METAMIZOL (2 g i.v. and 575 mg t...

Medical condition: Patients who underwent ambulatory surgery consisting in unilateral inguinal mesh hernioplasty

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	7.0		10022025		LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: ES (Completed)

Trial results: View results

EudraCT Number: 2005-002229-30

Sponsor Protocol Number: 26170

Start Date*: 2005-09-19

Sponsor Name:Serono España, S.A.

Full Title: Lutropin alfa in mid follicular phase in women at risk of poor response suppresed with cetrorelix: an exploratory trial.Lutropina alfa en mitad de la fase folicular en mujeres con riesgo de pobre r...

Medical condition: Controlled ovarian stimulation in assisted fertilisation. PT: assisted Fertilisation

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	7.0		10003539		PT

Population Age: Adults

Gender: Female

Trial protocol: ES (Completed)

Trial results: View results

EudraCT Number: 2004-001118-15	Sponsor Protocol Number: APL-B-005-02	Start Date*: 2004-10-27
Sponsor Name:Pharma Mar, S.A
Full Title: Phase II multicenter,open-label, clinical and pharmacokinetic study of Aplidin® as a 3-hour infusion every 2 weeks, in patients with advanced or metastatic transitional cell carcinoma of the uroth...
Medical condition: More than 90% of bladder carcinomas are transitional cell carcinomas (TCC) derived from the uroepithelium. About 6% to 8% are squamous cell carcinomas, and 2% are adenocarcinomas. Adenocarcinomas ...
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: ES (Completed)
Trial results: View results

EudraCT Number: 2004-004917-41

Sponsor Protocol Number: WX17801

Start Date*: 2005-09-05

Sponsor Name:Aspreva International Ltd.

Full Title: A prospective, randomized, active controlled, parallel group, multi-center trial to assess the efficacy and safety of mycophenolate mofetil (MMF) in inducing response and maintaining remission in s...

Medical condition: Lupus Nephritis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	4.1		10025140		Low

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) GB (Completed) HU (Completed) CZ (Completed) ES (Completed) BE (Completed) PT (Completed) AT (Prematurely Ended) IT (Completed)

Trial results: View results

EudraCT Number: 2006-004824-35

Sponsor Protocol Number: 309846

Start Date*: 2007-02-21

Sponsor Name:Schering AG

Full Title: A double-blind, randomized phase II study of once daily versus twice daily PTK787/ZK 222584 treatment in patients with advanced, previously treated metastatic adenocarcinoma of the colon or rectum

Medical condition: advanced, previously treated metastatic adenocarcinoma of the colon or rectum

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.1		10052362	Metastatic colorectal cancer	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Prematurely Ended) ES (Completed) FR (Completed)

Trial results: View results

EudraCT Number: 2004-001330-16

Sponsor Protocol Number: ACT5288

Start Date*: 2004-10-21

Sponsor Name:Sanofi-Synthélabo Recherche

Full Title: Estudio de Fase II, aleatorizado, multicéntrico, doble ciego y controlado con placebo, del efecto de SR57667B sobre la función dopaminérgica nigro-estriada, evaluado mediante imágenes PET 18F-Dopa ...

Medical condition: PARKINSON

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:			10061536		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Completed)

Trial results: View results

EudraCT Number: 2004-001253-29

Sponsor Protocol Number: KF-B-005-04

Start Date*: 2004-05-13

Sponsor Name:PharmaMar SAU

Full Title: Clinical and pharmacokinetic phase II study of one hour infusion of kahalalide F administered every week to patients with Non Small Cell Lung Cancer Stage IIIB with pleural effusion and stage IV, a...

Medical condition: Non Small Cell Lung Cancer Stage IIIB and IV after first Line Chemotherapy

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	5.0		10029514		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Completed)

Trial results: View results

EudraCT Number: 2005-004876-19

Sponsor Protocol Number: 01-05-TL-475-021

Start Date*: 2006-02-13

Sponsor Name:Takeda Europe R&D Centre Ltd

Full Title: A Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of TAK-475 100 mg or Placebo When Co-Administered With High Dose Statin Therapy in Subjects With Primary Hypercholesterolemia

Medical condition: Treatment of patients with primary hypercholesterolemia currently taking atorvastatin (80mg), simvastatin (80mg) or rosuvastatin (40mg)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8		10058108		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Prematurely Ended) ES (Completed) SE (Prematurely Ended) NO (Completed) FI (Prematurely Ended)

Trial results: View results

EudraCT Number: 2004-001144-71	Sponsor Protocol Number: D6160C00032	Start Date*: 2004-10-22
Sponsor Name:AstraZeneca AB
Full Title: A 24-Week Randomized, Double-Blind, Parallel-Group, Multi-Centre, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Tesaglitazar Therapy when Added to the Therapy of Pat...
Medical condition: Patients diagnosed with type 2 diabetes and treated with a single or multiple oral antidiabetic agents
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: ES (Completed)
Trial results: View results

EudraCT Number: 2004-000156-16

Sponsor Protocol Number: A509 1043

Start Date*: 2004-09-14

Sponsor Name:Pfizer AB

Full Title: Phase 3 multi center, double blind, randomized, parallel group evaluation of the fixed combination torcetrapib/atorvastatin, administered orally, once daily (QD), compared with atorvastatin alone, ...

Medical condition: Coronary Heart Disease

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:			10011078

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Prematurely Ended) ES (Completed) GB (Prematurely Ended)

Trial results: View results

EudraCT Number: 2005-004642-14	Sponsor Protocol Number: 20050100	Start Date*: 2006-01-30
Sponsor Name:Amgen S.A.
Full Title: Estudio abierto, de un solo grupo, de palifermin para la reducción de la mucositis en sujetos con linfoma no Hodgkin (LNH) o mieloma múltiple (MM) sometidos a quimioterapia a altas dosis y trasplan...
Medical condition: Mucositis Oral Oral Mucositis
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: ES (Completed)
Trial results: View results

EudraCT Number: 2004-001319-71	Sponsor Protocol Number: F1K-MC-EVBQ	Start Date*: 2004-08-13
Sponsor Name:Lilly S.A.
Full Title: A Phase IIIb Study to Determine Efficacy and Safety of Extended Drotrecogin Alfa (Activated) Therapy in Patients With Persistent Requirement for Vasopressor Support After 96-Hour Infusion With Comm...
Medical condition: in severe sepsis patients with persistent vasopressordependent hypotension
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: ES (Completed)
Trial results: View results

EudraCT Number: 2020-000658-83

Sponsor Protocol Number: GLPG3970-CL-209

Start Date*: 2020-10-21

Sponsor Name:Galapagos NV

Full Title: A randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety, tolerability, efficacy and pharmacokinetics of GLPG3970, administered orally for 6 weeks in adult subjects ...

Medical condition: Rheumatoid arthritis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	23.1	10028395 - Musculoskeletal and connective tissue disorders	10039073	Rheumatoid arthritis	PT

Population Age: Adults

Gender: Male, Female

Trial protocol: BG (Completed)

Trial results: View results

EudraCT Number: 2004-000243-23

Sponsor Protocol Number: Hx-CD4-109

Start Date*: 2004-08-03

Sponsor Name:Genmab A/S

Full Title: An Open-Label Therapeutic Exploratory Clinical Trial of HuMax-CD4, a Fully Human Monoclonal Anti-CD4 Antibody, in Patients with refractory or relapsed Non-Cutaneous CD4+ T-Cell Lymphoma

Medical condition: The mature non-cutaneous T-cell lymphomas expressing the CD4 molecule are the object of this protocol. 1.Peripheral T-cell lymphoma (PTCL) unspecified 2.Angioimmunnoblastic T-cell lymphoma 3.Anapl...

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	7.0		10042971		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Completed) DK (Completed)

Trial results: View results

EudraCT Number: 2006-003252-38

Sponsor Protocol Number: Hx-Inflam-302

Start Date*: 2006-09-01

Sponsor Name:Genmab A/S

Full Title: An open label clinical pilot study with local injection of human antibody (HuMax-Inflam) for the treatment of inflammatory psoriasis

Medical condition: inflammatory psoriasis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.1		10037153	Psoriasis	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Completed)

Trial results: View results

EudraCT Number: 2016-000712-15

Sponsor Protocol Number: 16-04/Imi-C

Start Date*: 2017-02-24

Sponsor Name:Dermapharm AG

Full Title: Double-blind, randomised clinical study comparing efficacy and safety of Imiquimod 5% Cream (Test) vs. Aldara® 5% Cream (Reference) vs. Vehicle in patients with actinic keratosis

Medical condition: Actinic keratosis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10040785 - Skin and subcutaneous tissue disorders	10000614	Actinic keratosis	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2015-000968-34

Sponsor Protocol Number: CAMN107ADE20

Start Date*: 2015-10-07

Sponsor Name:Novartis Pharma GmbH

Full Title: A Phase IV single arm, multicenter, open-label study assessing deep molecular response in adult patients with newly diagnosed Philadelphia chromosome positive CML in chronic phase after two years o...

Medical condition: The trial aims to evaluate the efficacy and quality of life of nilotinib 300mg BID in patients with chronic myleoid leukemia in chronic phase.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	100000004864	10009700	CML	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2008-002102-19

Sponsor Protocol Number: VEG108844

Start Date*: 2008-11-24

Sponsor Name:GlaxoSmithKline Research & Development Ltd

Full Title: Study VEG108844, a Study of Pazopanib versus Sunitinib in the Treatment of Subjects with Locally Advanced and/or Metastatic Renal Cell Carcinoma

Medical condition: Locally Advanced and/or Metastatic Renal Cell Carcinoma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10050513	Metastatic renal cell carcinoma	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IE (Completed) GB (Completed) ES (Completed) SE (Completed) NL (Completed) IT (Completed) DE (Completed)

Trial results: View results

EudraCT Number: 2015-005707-92

Sponsor Protocol Number: 16-03/MicoFlu-C

Start Date*: 2016-11-07

Sponsor Name:Dermapharm AG

Full Title: Double-blind, randomised clinical study comparing efficacy and safety of Miconazole 2% Fluprednidene 0.1% Cream (Test) vs. Vobaderm® Cream (Reference) vs. Vehicle in patients with moderate to sever...

Medical condition: moderate to severely inflamed candidiasis of the skin

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	19.0	100000004862	10007159	Candidiasis of skin and nails	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2013-001062-41	Sponsor Protocol Number: 13-005	Start Date*: 2013-06-12
Sponsor Name:RWTH Aachen University, represented by the Rector, himself represented by Clinical Trial Center (CTC-A) [...] 1. RWTH Aachen University, represented by the Rector, himself represented by Clinical Trial Center (CTC-A) 2. RWTH Aachen University, represented by the Rector, himself represented by Clinical Trial Center (CTC-A) 3. RWTH Aachen University, represented by the Rector, himself represented by Clinical Trial Center (CTC-A)
Full Title: Neoadjuvant chemotherapy with Cabazitaxel in high risk prostate cancer patients prior to radical prostatectomy
Medical condition: high-risk prostata cancer patients
Disease:
Population Age: Adults, Elderly		Gender: Male
Trial protocol: DE (Prematurely Ended)
Trial results: View results

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

For support, Contact us.

The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

European Medicines Agency © 1995-Sun Jun 01 11:20:09 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA